Detalles de la búsqueda
1.
Impaired Reorganization of Centrosome Structure Underlies Human Infantile Dilated Cardiomyopathy.
Circulation
; 147(17): 1291-1303, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-36970983
2.
A bistable, multiport valve enables microformulators creating microclinical analyzers that reveal aberrant glutamate metabolism in astrocytes derived from a tuberous sclerosis patient.
Sens Actuators B Chem
; 3412021 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34092923
3.
A novel manganese-dependent ATM-p53 signaling pathway is selectively impaired in patient-based neuroprogenitor and murine striatal models of Huntington's disease.
Hum Mol Genet
; 24(7): 1929-44, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25489053
4.
Reduced bioavailable manganese causes striatal urea cycle pathology in Huntington's disease mouse model.
Biochim Biophys Acta Mol Basis Dis
; 1863(6): 1596-1604, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28213125
5.
Metabolic consequences of inflammatory disruption of the blood-brain barrier in an organ-on-chip model of the human neurovascular unit.
J Neuroinflammation
; 13(1): 306, 2016 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27955696
6.
PARK2 patient neuroprogenitors show increased mitochondrial sensitivity to copper.
Neurobiol Dis
; 73: 204-12, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25315681
7.
Contractile and Genetic Characterization of Cardiac Constructs Engineered from Human Induced Pluripotent Stem Cells: Modeling of Tuberous Sclerosis Complex and the Effects of Rapamycin.
Bioengineering (Basel)
; 11(3)2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534508
8.
Rescue of impaired blood-brain barrier in tuberous sclerosis complex patient derived neurovascular unit.
J Neurodev Disord
; 16(1): 27, 2024 May 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38783199
9.
Rescue of Impaired Blood-Brain Barrier in Tuberous Sclerosis Complex Patient Derived Neurovascular Unit.
bioRxiv
; 2023 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38168450
10.
Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions.
NPJ Parkinsons Dis
; 8(1): 84, 2022 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768426
11.
Cortical regulation of striatal medium spiny neuron dendritic remodeling in parkinsonism: modulation of glutamate release reverses dopamine depletion-induced dendritic spine loss.
Cereb Cortex
; 20(10): 2423-32, 2010 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-20118184
12.
Environmentally relevant developmental methylmercury exposures alter neuronal differentiation in a human-induced pluripotent stem cell model.
Food Chem Toxicol
; 152: 112178, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33831500
13.
Cortical serotonin and norepinephrine denervation in parkinsonism: preferential loss of the beaded serotonin innervation.
Eur J Neurosci
; 30(2): 207-16, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19659923
14.
Huntington's disease associated resistance to Mn neurotoxicity is neurodevelopmental stage and neuronal lineage dependent.
Neurotoxicology
; 75: 148-157, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31545971
15.
Author Correction: Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.
Sci Rep
; 8(1): 8266, 2018 May 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29795393
16.
Systemic administration of a proteasome inhibitor does not cause nigrostriatal dopamine degeneration.
Brain Res
; 1168: 83-9, 2007 Sep 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-17706185
17.
From the Cover: Manganese and Rotenone-Induced Oxidative Stress Signatures Differ in iPSC-Derived Human Dopamine Neurons.
Toxicol Sci
; 159(2): 366-379, 2017 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28962525
18.
Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.
Fluids Barriers CNS
; 14(1): 9, 2017 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28407791
19.
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.
Sci Rep
; 7(1): 5280, 2017 07 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28706199
20.
Genomic Instability Associated with p53 Knockdown in the Generation of Huntington's Disease Human Induced Pluripotent Stem Cells.
PLoS One
; 11(3): e0150372, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26982737